Published Oct 24, 2026, 10:30 AM ET · Updated 20 days ago · 2 sources
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
CNBC Markets
·
Original Report
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.